Day: March 9, 2022

WISeKey’s WISeID Platform Helps Individuals and Companies Reduce Cybersecurity Risks WISeKey offers free access to cybersecurity services to anyone in need of protecting their digital assets GENEVA – March 9, 2022: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, AI, Blockchain and IoT company, today announced that it has enabled free access to its WISeID cyber security platform of services, aiming to reduce the attack-surface on digital assets and personal information, and securely dematerialize electronic transactions. WISeID, based on the WISeKey/OISTE Root of Trust, integrates innovative technologies to offer any individual or business entity, the ability to create an account, accessing several basic services, free of charge, which then can be upgraded to access additional multiple...

GHENT, Belgium, March 09, 2022 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces that Ian Crosbie, Chief Executive Officer, will present at the following upcoming investor conferences in March 2022:BioCapital Europe, Amsterdam, 10 March 2022Presentation by Ian Crosbie, CEO, on Thursday 10 March at 15:20 CETOppenheimer’s 32nd Annual Healthcare Conference, Virtual format, 15-17 March 2022Presentation by Ian Crosbie, CEO, on Thursday 17 March at 10:00 am ET / 16:00 CETSequana Medical will be meeting with international investors in 1-to-1 and small group meetings. Presentation slides will be available on Sequana Medical’s Investors...

BERKELEY, Calif., March 08, 2022 (GLOBE NEWSWIRE) — Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that preclinical data from CB-011, its allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma (r/r MM), will be presented as a poster at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2022, held April 8-13, 2022 in New Orleans. CB-011 is the first allogeneic CAR-T cell therapy immune-cloaked to prevent both T- and NK-mediated immune cell rejection. This allogeneic anti-BCMA CAR-T cell therapy is engineered using Cas12a chRDNA technology to insert a BCMA-specific CAR into the TRAC gene and armor the cells with an immune cloaking strategy that includes a knockout of the endogenous...

VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) — American Lithium Corp. (“American Lithium” or the Company”) (TSX-V: LI, OTCQB: LIACF, Frankfurt: 5LA1) is pleased to announce that it has been invited to participate at the 34th Annual ROTH Conference on March 13-15, 2022, in Dana Point, California. This annual investment conference will feature presentations from companies across a variety of industry sectors followed by face-to-face appointments, small group meetings, analyst-selected fireside chats, thematic industry panels. During previous events, Roth has hosted close to 550 participating companies and attracted more than 5,000 attendees, including institutional investors, analysts, family offices and high-net-worth investors. Company CEO Simon Clarke along with President and COO Dr. Laurence Stefan will participate...

Lucid Air – EV AC Charging ‘Powered By ROHM’Powered by ROHM ROHM’s SiC MOSFETs enable efficient on-board charging for Lucid Air EVSanta Clara, CA and Kyoto, Japan, March 08, 2022 (GLOBE NEWSWIRE) — ROHM Semiconductor has announced that Lucid, an advanced luxury electric vehicle company headquartered in California, is using its silicon carbide metal-oxide-semiconductor field effect transistor (SiC MOSFET) in the ground-breaking Lucid Air. The Wunderbox, the main on-board charging unit in the Lucid Air, integrates a DC-DC converter and the Bi-directional On-Board Charger (OBC), where an advanced power factor correction circuit is capable of operating at high switching frequencies thanks to the superior performance of the SiC MOSFET. The improved performance at high frequency and high temperature of ROHM’s SCT3040K...